(Q45093832)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

title

Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference

R. H. Mindham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4571143

6 February 2023

R. Gaind

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4571143

6 February 2023

B. H. Anstee

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4571143

6 February 2023

L. Rimmer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4571143

6 February 2023

language of work or name

English

0 references

publication date

1 November 1972

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

30 September 2019

https://www.cambridge.org/core/services/aop-cambridge-core/content/view/S0033291700045220

1 reference

10.1017/S0033291700045220

DOI

https://api.crossref.org/works/10.1017/S0033291700045220

6 February 2023

published in

Psychological Medicine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

406-413

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

Trial of amantadine in epidemic influenza

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

The toxicologic and pharmacologic properties of amantadine hydrochloride.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Amantadine in depression.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Studies on induced influenza in man. I. Double-blind studies designed to assess prophylactic efficacy of amantadine hydrochloride against a2/Rockville/1/65 strain

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Controlled trial of amantadine hydrochloride in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

WITHDRAWAL OF MAINTENANCE ANTIPARKINSON DRUG IN THE PHENOTHIAZINE-INDUCED EXTRAPYRAMIDAL REACTION

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Amantadine in parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Effects of L-dopa in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

A Comparison of Alternative Tests of Significance for the Problem of $m$ Rankings

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Reversibility of drug-induced parkinsonism.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

A CRITICAL ANALYSIS OF THE EFFECTS OF TRIHEXYPHENIDYL (ARTANE) ON THE COMPONENTS OF THE PARKINSONIAN SYNDROME

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

A survey of drug-induced extrapyramidal reactions

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Use of Amantadine in Parkinson's Disease. Results of a Double-blind Trial

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Amantadine-Dopamine Interaction: Possible Mode of Action in Parkinsonism

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

The Use of Ranks to Avoid the Assumption of Normality Implicit in the Analysis of Variance

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

Potentiation by amantadine hydrochloride of L-dopa-induced effects in mice.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

On the mode of action of amantadine.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

A SELF-RATING DEPRESSION SCALE

1 reference

https://api.crossref.org/works/10.1017%2FS0033291700045220

7 January 2021

KEMADRIN IN THE TREATMENT OF PARKINSONISM: A DOUBLE BLIND AND ONE-YEAR FOLLOW-UP STUDY

9

1 reference

10.1017/S0033291700045220

DOI

https://api.crossref.org/works/10.1017/S0033291700045220

10.1017/S0033291700045220

6 February 2023

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4571143%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference